How Barrett was paid
$4.3M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Stock | Incentive | Other | Total |
|---|---|---|---|---|---|---|
| Elizabeth BarrettChief Executive Officer | $855,590 | $774,066 | $2,122,211 | $516,263 | $42,494 | $4,310,624 |
| Mark SchoenbergChief Medical Officer | $369,607 | $167,500 | $440,400 | $180,000 | $13,133 | $1,170,640 |
| Jason SmithGeneral Counsel and Chief Compliance Officer | $492,011 | $198,960 | $220,200 | $197,920 | $89,527 | $1,198,618 |
What changed and why
- $4.3MElizabeth Barrett received total compensation of $4,310,624 in 2025 compared to $4,149,858 in 2024.
- Half of the CEO long-term incentive awards were performance stock units tied to cumulative net product sales.
- Discretionary bonuses for 2025 were approved by the Board based on overall business and individual performance.
- 89%Say-on-pay received over 89 percent support at the 2025 annual meeting.
Other UroGen Pharma proxy statements
- 2025 proxy statement
Elizabeth Barrett paid $4.1M (-11% on the year).
Filed Jul 15, 2025
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.